Clinical Trial Update: Piloting 18F-FAPI PET/MRI for Applications in Breast Cancer [NA]

View source ↗

Summary

A pilot study is planned to evaluate 18F-FAPI PET/MRI imaging for breast cancer, sponsored by St. Olavs Hospital, with the trial status NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 18F-FAPI PET tracer (18F-labeled fibroblast activation protein inhibitor)

Snippet

Sponsor: St. Olavs Hospital | Conditions: Breast Neoplasm Female | NA | Status: NOT_YET_RECRUITING